464 related articles for article (PubMed ID: 19563474)
1. Application of array-based whole genome scanning technologies as a cytogenetic tool in haematological malignancies.
Maciejewski JP; Tiu RV; O'Keefe C
Br J Haematol; 2009 Sep; 146(5):479-88. PubMed ID: 19563474
[TBL] [Abstract][Full Text] [Related]
2. Combined array-comparative genomic hybridization and single-nucleotide polymorphism-loss of heterozygosity analysis reveals complex genetic alterations in cervical cancer.
Kloth JN; Oosting J; van Wezel T; Szuhai K; Knijnenburg J; Gorter A; Kenter GG; Fleuren GJ; Jordanova ES
BMC Genomics; 2007 Feb; 8():53. PubMed ID: 17311676
[TBL] [Abstract][Full Text] [Related]
3. Single-nucleotide polymorphism array (SNP-A) improves the identification of chromosomal abnormalities by metaphase cytogenetics in myelodysplastic syndrome.
da Silva FB; Machado-Neto JA; Bertini VHLL; Velloso EDRP; Ratis CA; Calado RT; Simões BP; Rego EM; Traina F
J Clin Pathol; 2017 May; 70(5):435-442. PubMed ID: 27836923
[TBL] [Abstract][Full Text] [Related]
4. Genome-wide genetic characterization of an atypical meningioma by single-nucleotide polymorphism array-based mapping and classical cytogenetics.
Krupp W; Holland H; Koschny R; Bauer M; Schober R; Kirsten H; Livrea M; Meixensberger J; Ahnert P
Cancer Genet Cytogenet; 2008 Jul; 184(2):87-93. PubMed ID: 18617056
[TBL] [Abstract][Full Text] [Related]
5. High-resolution analysis of allelic imbalance in neuroblastoma cell lines by single nucleotide polymorphism arrays.
Carr J; Bown NP; Case MC; Hall AG; Lunec J; Tweddle DA
Cancer Genet Cytogenet; 2007 Jan; 172(2):127-38. PubMed ID: 17213021
[TBL] [Abstract][Full Text] [Related]
6. Whole genome scanning as a cytogenetic tool in hematologic malignancies.
Maciejewski JP; Mufti GJ
Blood; 2008 Aug; 112(4):965-74. PubMed ID: 18505780
[TBL] [Abstract][Full Text] [Related]
7. Detection of cryptic chromosomal lesions including acquired segmental uniparental disomy in advanced and low-risk myelodysplastic syndromes.
Gondek LP; Haddad AS; O'Keefe CL; Tiu R; Wlodarski MW; Sekeres MA; Theil KS; Maciejewski JP
Exp Hematol; 2007 Nov; 35(11):1728-38. PubMed ID: 17920760
[TBL] [Abstract][Full Text] [Related]
8. Molecular cytogenetics.
Kearney L
Best Pract Res Clin Haematol; 2001 Sep; 14(3):645-69. PubMed ID: 11640874
[TBL] [Abstract][Full Text] [Related]
9. Genome-wide arrays in routine diagnostics of hematological malignancies.
Simons A; Sikkema-Raddatz B; de Leeuw N; Konrad NC; Hastings RJ; Schoumans J
Hum Mutat; 2012 Jun; 33(6):941-8. PubMed ID: 22488943
[TBL] [Abstract][Full Text] [Related]
10. High-resolution copy number array in the molecular cytogenetic diagnostics of pediatric malignant hematological disorders.
Wikhager C; Ögärd I; Martinsson T; Abrahamsson J; Palmqvist L; Sjögren H
Oncol Rep; 2012 May; 27(5):1429-34. PubMed ID: 22344473
[TBL] [Abstract][Full Text] [Related]
11. The advantage of using SNP array in clinical testing for hematological malignancies--a comparative study of three genetic testing methods.
Xu X; Johnson EB; Leverton L; Arthur A; Watson Q; Chang FL; Raca G; Laffin JJ
Cancer Genet; 2013; 206(9-10):317-26. PubMed ID: 24269304
[TBL] [Abstract][Full Text] [Related]
12. SNP-based arrays complement classic cytogenetics in the detection of chromosomal aberrations in Wilms' tumor.
Zin R; Pham K; Ashleigh M; Ravine D; Waring P; Charles A
Cancer Genet; 2012 Mar; 205(3):80-93. PubMed ID: 22469507
[TBL] [Abstract][Full Text] [Related]
13. Clinical utilization of high-resolution single nucleotide polymorphism based oligonucleotide arrays in diagnostic studies of pediatric patients with solid tumors.
Dougherty MJ; Tooke LS; Sullivan LM; Hakonarson H; Wainwright LM; Biegel JA
Cancer Genet; 2012; 205(1-2):42-54. PubMed ID: 22429597
[TBL] [Abstract][Full Text] [Related]
14. Single-nucleotide polymorphism array karyotyping in clinical practice: where, when, and how?
Sato-Otsubo A; Sanada M; Ogawa S
Semin Oncol; 2012 Feb; 39(1):13-25. PubMed ID: 22289488
[TBL] [Abstract][Full Text] [Related]
15. Molecular karyotyping using an SNP array for genomewide genotyping.
Rauch A; Rüschendorf F; Huang J; Trautmann U; Becker C; Thiel C; Jones KW; Reis A; Nürnberg P
J Med Genet; 2004 Dec; 41(12):916-22. PubMed ID: 15591277
[TBL] [Abstract][Full Text] [Related]
16. Integration of microarray analysis into the clinical diagnosis of hematological malignancies: How much can we improve cytogenetic testing?
Peterson JF; Aggarwal N; Smith CA; Gollin SM; Surti U; Rajkovic A; Swerdlow SH; Yatsenko SA
Oncotarget; 2015 Aug; 6(22):18845-62. PubMed ID: 26299921
[TBL] [Abstract][Full Text] [Related]
17. Historical prospective of human cytogenetics: from microscope to microarray.
Smeets DF
Clin Biochem; 2004 Jun; 37(6):439-46. PubMed ID: 15183291
[TBL] [Abstract][Full Text] [Related]
18. Genomic alterations in renal tumours: what have we learned in the era of comparative genomic hybridisation?
Moch H
Pathology; 2004 Feb; 36(1):51-7. PubMed ID: 14757557
[TBL] [Abstract][Full Text] [Related]
19. Oligo-based High-resolution aCGH Analysis Enhances Routine Cytogenetic Diagnostics in Haematological Malignancies.
Kjeldsen E
Cancer Genomics Proteomics; 2015; 12(6):301-37. PubMed ID: 26543079
[TBL] [Abstract][Full Text] [Related]
20. High-density genome array is superior to fluorescence in-situ hybridization analysis of monosomy 3 in choroidal melanoma fine needle aspiration biopsy.
Young TA; Burgess BL; Rao NP; Gorin MB; Straatsma BR
Mol Vis; 2007 Dec; 13():2328-33. PubMed ID: 18199974
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
